Quintana FJ. Astrocytes play a crucial role in the formation and evolution of MS lesions - Commentary. Mult Scler. 2019;25(1):19-20. doi:10.1177/1352458518796693
Hu D, Notarbartolo S, Croonenborghs T, et al. Transcriptional signature of human pro-inflammatory T17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat Commun. 2017;8(1):1600. doi:10.1038/s41467-017-01571-8
Wheeler MA, Quintana FJ. Regulation of Astrocyte Functions in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2019;9(1). doi:10.1101/cshperspect.a029009
Patsopoulos NA. Genetics of Multiple Sclerosis: An Overview and New Directions. Cold Spring Harb Perspect Med. 2018;8(7). doi:10.1101/cshperspect.a028951
Lee JY, De Jager PL. What is the epigenome and is it involved in multiple sclerosis?. Mult Scler. 2018;24(3):268-269. doi:10.1177/1352458517750769
Rothhammer V, Borucki DM, Kenison JE, et al. Detection of aryl hydrocarbon receptor agonists in human samples. Sci Rep. 2018;8(1):4970. doi:10.1038/s41598-018-23323-4
Ma Y, De Jager PL. Designing an epigenomic study. Mult Scler. 2018;24(5):604-609. doi:10.1177/1352458517750770
Klein HU, De Jager PL. How do we measure the epigenome(s)?. Mult Scler. 2018;24(4):446-448. doi:10.1177/1352458517750772
Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557(7707):724-728. doi:10.1038/s41586-018-0119-x
Roostaei T, De Jager PL. Evaluating the role of genetic variation in the epigenome in health and disease. Mult Scler. 2018;24(6):707-709. doi:10.1177/1352458517751651